Article

Lupus Nephritis: New Guidance for Rheumatologists

Lupus nephritis treatment is the focus of new guidelines from the American College of Rheumatology. Bevra Hahn MD of UCLA reveals the highlights in this podcast.

The American College of Rheumatology has issued new guidelines on the latest in treatment for lupus nephritis. In this podcast, the head of the guidelines panel, Bevra Hahn, MD, discusses the highlights of the guidelines. 

Dr. Hahn is professor of medicine and chief of the division of rheumatology at the University of California-Los Angeles Medical Center.

Questions:

1. Why did the American College of Rheumatology choose to separate out lupus nephritis from its guidelines on lupus?
2 .How is this guideline different from earlier guidance on the same subject?
3. What are the main advantage of the guidelines for rheumatologists?
4. What would you say are the chief limitations of the guideline as it is written today?

 

Lupus Nephritis: New Guidance for Rheumatologists

For your reference:

American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis

Arthritis Care & Research, Volume 64, Issue 6, pages 797–808, June 2012


 

 

Related Videos
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Orrin Troum, MD: Accurately Imaging Gout With DECT Scanning
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Related Content
Black and white FDA logo | Credit: US Food and Drug Administration
February 5th 2025

FDA Fast Tracks CAR-T Therapy for Lupus

Abigail Brooks, MA
Emerging Agents in the Treatment of Rheumatic Diseases
October 2nd 2023

Emerging Agents in the Treatment of Rheumatic Diseases

Nehad Soloman, MD, FACR Andrew Sharobeem, DO, FACR Philip J. Mease, MD
Gerd R. Burmester, MD, Professor of Medicine, Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, and Humboldt University and Free University
February 4th 2025

Tocilizumab Biosimilar Approved for Rheumatological Diseases, COVID-19

Victoria Johnson
Challenges with Step Therapy Protocols in Treating Rheumatoid Arthritis
August 31st 2023

Challenges with Step Therapy Protocols in Treating Rheumatoid Arthritis

Nehad Soloman, MD, FACR Andrew Sharobeem, DO, FACR John B. Boone, MD, FACR Madelaine Feldman MD, FACR
Ryan Stultz, MD, PhD, Clinician Researcher, Division of Rheumatology, University of Washington, Seattle
January 29th 2025

NLR and MLR May Predict Gout Flare and CVD Mortality Risk

Victoria Johnson
Fibromyalgia Common in People With IBD
January 28th 2025

Fibromyalgia Common in People With IBD

Victoria Johnson
© 2025 MJH Life Sciences

All rights reserved.